New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
07:31 EDTDSCO, XLRN, GERN, ARGS, THLD, MDCO, EGRX, ANAC, SGMO, INSYPiper Jaffray to hold a symposium
Catalyst Symposium to be held in Boston on July 8.
News For ANAC;ARGS;DSCO;EGRX;GERN;INSY;MDCO;XLRN;SGMO;THLD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
07:32 EDTEGRXEagle Pharmaceuticals price target raised to $51 from $37 at Cantor
Cantor increased its price target on Eagle (EGRX) after the FDA found that Teva's (TEVA) liquid Treanda drug is incompatible with various commonly used polycarbonate-containing injection devices, while the Treanda that Eagle licensed to Teva does not have this problem. The firm thinks this discrepancy will create a number of benefits for Eagle, and it reiterates a Buy rating on the stock.
March 30, 2015
16:10 EDTARGSArgos Therapeutics provides 2015 anticipated milestones
The following are expected in 2015: Full enrollment and randomization in the phase 3 ADAPT trial for AGS-003 in mRCC expected by the end of second quarter 2015; Interim data analyses from the ADAPT trial by the IDMC expected in second quarter at approximately 25% of events and late 2015 at approximately 50% of events; Investigator-initiated phase 2 trials with AGS-003 in other tumor types and in other RCC settings, including early stage RCC and non-clear cell mRCC, planned for 2015; Continue investigator-initiated phase 2 adult eradication trial for AGS-004 in HIV; investigator-initiated phase 2 pediatric trial planned for second half of 2015; Continue the build-out and equipping of Argos' automated commercial manufacturing facility.
16:09 EDTARGSArgos Therapeutics reports Q4 EPS (83c), consensus (73c)
Subscribe for More Information
07:05 EDTMDCOThe Medicines Co. receives EC approval for three hospital acute care products
Subscribe for More Information
March 27, 2015
08:44 EDTMDCOThe Medicines Co. has a conference call hosted by JPMorgan
Subscribe for More Information
06:08 EDTMDCOThe Medicines Co. assumed with a Neutral at Citigroup
Target $30.
March 26, 2015
10:04 EDTARGSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:40 EDTARGSArgos Therapeutics initiated with a Buy at Roth Capital
Target $21.
07:30 EDTINSYDeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 25, 2015
07:16 EDTSGMO, ARGSPiper Jaffray and the Alliance for Regenerative Medicine co-host conference
3rd Annual Regenerative Medicine Investor Day is being held in New York on March 25 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link
07:12 EDTMDCOAmerican Academy of Orthopedic Surgeons to hold annual meeting
Subscribe for More Information
07:00 EDTEGRXEagle Pharmaceuticals management to meet with Piper Jaffray
Subscribe for More Information
March 23, 2015
10:31 EDTINSYInsys Therapeutics management to meet with JMP Securities
Subscribe for More Information
09:03 EDTANACLeerink analysts hold a meeting with a conference call hookup
Subscribe for More Information
March 20, 2015
10:00 EDTMDCOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
March 19, 2015
16:06 EDTMDCOThe Medicines Co. initiated with a Neutral at Mizuho
Subscribe for More Information
10:25 EDTANACAnacor management to meet with Jefferies
Subscribe for More Information
March 18, 2015
10:08 EDTEGRXEagle Pharmaceuticals price target increased to $67 from $43 at William Blair
William Blair raised its price target on Eagle Pharmaceuticals to $67 from $43 citing its belief that the company can become profitable and have significant cash flow pending the approval of EP-3102. The company added that it view last week's FDA label change for Teva's (TEVA) Treanda as a positive for EP-3102 and that its new price target assumes 2016 launch and "reasonable" penetration for EP-3102.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use